Hsbc Holdings PLC Biogen Inc. Put Options Transaction History

Hsbc Holdings PLC

$160 Billion
Q2 2024

Put Options

22 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 12, 2024	SELL	$190.52 - $236.72 $685,872 - $852,192	-3,600 Reduced 80.0%	900 $208,000
Q1 2024 May 15, 2024	SELL	$212.02 - $267.71 $1.14 Million - $1.45 Million	-5,400 Reduced 54.55%	4,500 $970,000
Q4 2023 Feb 12, 2024	SELL	$222.59 - $267.94 $890,360 - $1.07 Million	-4,000 Reduced 28.78%	9,900 $2.56 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $303,960 - $343,068	-1,200 Reduced 7.95%	13,900 $3.57 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $3.14 Million - $3.63 Million	11,400 Added 308.11%	15,100 $4.3 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $3.08 Million - $3.51 Million	-12,000 Reduced 76.43%	3,700 $1.03 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $1.39 Million - $1.69 Million	5,500 Added 53.92%	15,700 $4.35 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.99 Million - $2.74 Million	10,200 New	10,200 $2.75 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $174,393 - $219,726	-900 Reduced 36.0%	1,600 $337,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $223,920 - $287,770	1,000 Added 66.67%	2,500 $599,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $20.8 Million - $33.4 Million	-80,418 Reduced 98.17%	1,500 $519,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $19.1 Million - $28.8 Million	80,918 Added 8091.8%	81,918 $20.1 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $476,585 - $550,278	-1,800 Reduced 64.29%	1,000 $284,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $22.9 Million - $29 Million	-85,100 Reduced 96.81%	2,800 $872,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $8.34 Million - $11.5 Million	-37,900 Reduced 30.13%	87,900 $26 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $43,488 - $48,776	200 Added 0.16%	125,800 $29.3 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $5.02 Million - $5.54 Million	-22,900 Reduced 15.42%	125,600 $29.4 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $2.71 Million - $4.24 Million	12,500 Added 9.19%	148,500 $35.1 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $6.99 Million - $8.85 Million	25,100 Added 22.63%	136,000 $40.9 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $20.4 Million - $26.6 Million	69,400 Added 167.23%	110,900 $39.2 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $8.33 Million - $11.8 Million	32,027 Added 338.09%	41,500 $11.4 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $2.66 Million - $3.12 Million	9,473	9,473 $2.97 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$3.17 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$3.12 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.77 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.35 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$1.08 Billion
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account